Holmlin R. Erik's Form 4 filing
Bionano Genomics, Inc. (BNGO) · filed May 16, 2023
- Accession no.
- 0001411690-23-000032
- Filed
- May 16, 2023
- Trade date
- May 16, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $9.60K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Holmlin R. ErikCIK 0001579988 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Common Stock | PPurchaseAcquired | +15,000 | $0.64F1 | +$9,600 | 806,474 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.64160 to $0.643099, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Referenced by the price of 1 transaction in Table I.